THRAP3
Basic information
Region (hg38): 1:36224432-36305357
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the THRAP3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 36 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 36 | 2 | 0 |
Variants in THRAP3
This is a list of pathogenic ClinVar variants found in the THRAP3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-36282606-C-T | not specified | Uncertain significance (Nov 09, 2022) | ||
1-36282607-G-A | not specified | Uncertain significance (May 05, 2023) | ||
1-36282667-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
1-36282679-G-A | not specified | Uncertain significance (Nov 29, 2023) | ||
1-36286514-C-T | not specified | Uncertain significance (Jun 13, 2023) | ||
1-36286541-A-G | not specified | Uncertain significance (Dec 15, 2022) | ||
1-36286565-A-G | not specified | Uncertain significance (Oct 05, 2023) | ||
1-36286579-G-T | not specified | Uncertain significance (Nov 07, 2022) | ||
1-36286688-G-A | not specified | Uncertain significance (Apr 11, 2023) | ||
1-36286697-G-A | not specified | Uncertain significance (May 23, 2023) | ||
1-36286738-G-C | not specified | Uncertain significance (Apr 22, 2024) | ||
1-36286810-G-A | not specified | Uncertain significance (May 26, 2022) | ||
1-36286933-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
1-36286963-C-G | not specified | Uncertain significance (Aug 22, 2023) | ||
1-36286963-C-T | not specified | Uncertain significance (Nov 09, 2022) | ||
1-36286985-A-G | not specified | Uncertain significance (Jul 27, 2022) | ||
1-36287026-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
1-36287063-C-A | not specified | Uncertain significance (Jun 13, 2024) | ||
1-36287102-C-T | not specified | Uncertain significance (May 02, 2024) | ||
1-36287113-T-G | not specified | Likely benign (Apr 28, 2023) | ||
1-36289060-G-A | not specified | Likely benign (Nov 13, 2023) | ||
1-36289065-T-C | not specified | Uncertain significance (Apr 09, 2024) | ||
1-36289121-G-A | not specified | Uncertain significance (Oct 05, 2022) | ||
1-36289239-A-G | not specified | Uncertain significance (Jan 04, 2022) | ||
1-36289265-G-A | not specified | Uncertain significance (May 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
THRAP3 | protein_coding | protein_coding | ENST00000354618 | 10 | 80942 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000201 | 125741 | 0 | 5 | 125746 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.16 | 416 | 560 | 0.743 | 0.0000347 | 6194 |
Missense in Polyphen | 197 | 236.85 | 0.83175 | 2986 | ||
Synonymous | -0.0994 | 194 | 192 | 1.01 | 0.00000971 | 1886 |
Loss of Function | 5.89 | 4 | 48.1 | 0.0832 | 0.00000346 | 527 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000153 | 0.000152 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in pre-mRNA splicing. Remains associated with spliced mRNA after splicing which probably involves interactions with the exon junction complex (EJC). Can trigger mRNA decay which seems to be independent of nonsense-mediated decay involving premature stop codons (PTC) recognition. May be involved in nuclear mRNA decay. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45 is proposed to sequester phosphorylated SFPQ from PTPRC/CD45 pre-mRNA in resting T-cells. Involved in cyclin-D1/CCND1 mRNA stability probably by acting as component of the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Involved in response to DNA damage. Is excluced from DNA damage sites in a manner that parallels transcription inhibition; the function may involve the SNARP complex. Initially thought to play a role in transcriptional coactivation through its association with the TRAP complex; however, it is not regarded as a stable Mediator complex subunit. Cooperatively with HELZ2, enhances the transcriptional activation mediated by PPARG, maybe through the stabilization of the PPARG binding to DNA in presence of ligand. May play a role in the terminal stage of adipocyte differentiation. Plays a role in the positive regulation of the circadian clock. Acts as a coactivator of the CLOCK-ARNTL/BMAL1 heterodimer and promotes its transcriptional activator activity and binding to circadian target genes (PubMed:24043798). {ECO:0000269|PubMed:20123736, ECO:0000269|PubMed:20932480, ECO:0000269|PubMed:22424773, ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:24043798}.;
- Pathway
- Interactome of polycomb repressive complex 2 (PRC2);Developmental Biology;Transcriptional regulation of white adipocyte differentiation
(Consensus)
Recessive Scores
- pRec
- 0.255
Intolerance Scores
- loftool
- rvis_EVS
- -0.62
- rvis_percentile_EVS
- 17.4
Haploinsufficiency Scores
- pHI
- 0.245
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.579
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.952
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Thrap3
- Phenotype
Gene ontology
- Biological process
- regulation of alternative mRNA splicing, via spliceosome;nuclear-transcribed mRNA catabolic process;transcription initiation from RNA polymerase II promoter;mRNA processing;circadian rhythm;RNA splicing;intracellular steroid hormone receptor signaling pathway;androgen receptor signaling pathway;positive regulation of circadian rhythm;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of mRNA splicing, via spliceosome;mRNA stabilization
- Cellular component
- nucleus;nucleoplasm;mediator complex;nuclear speck;exon-exon junction complex;extracellular exosome
- Molecular function
- RNA polymerase II distal enhancer sequence-specific DNA binding;transcription coregulator activity;transcription coactivator activity;RNA binding;protein binding;ATP binding;nuclear receptor transcription coactivator activity;signaling receptor activity;vitamin D receptor binding;thyroid hormone receptor binding;phosphoprotein binding